Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children

A. Locasciulli, J. Vossen, A. Bacigalupo, J. Hows, M. T. VanLint, E. Gluckman, C. Nissen, S. McCann, M. De Planque, L. Van'tVeer, A. Ragavashar, A. Marin

Research output: Contribution to journalArticlepeer-review

Abstract

The SAA Registry of the EBMT now contains data on 171 children younger than 15 years of age with acquired SAA and undergoing BMT between 1970 and 1988. The overall actuarial survival is 63% at 10 years. In a multivariate Cox analysis, the year of transplant was the most important prognostic factor with a significant advantage for children grafted in 1984-88 (81%) vs. 1981-83 (67%) and 1970-80 (41%) (p=0.02). Cyclosporine A given for GVHD prophylaxis, no treatment before transplant and an interval

Original languageEnglish
Pages (from-to)123-125
Number of pages3
JournalBone Marrow Transplantation
Volume4
Issue numberSUPPL. 4
Publication statusPublished - 1989

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Fingerprint Dive into the research topics of 'Allogeneic bone marrow transplantation (BMT) for acquired severe aplastic anaemia (SAA) in children'. Together they form a unique fingerprint.

Cite this